Illumina, Inc.
Diamond Hill views Illumina as the leading producer of next-generation sequencing systems used in DNA research and increasingly in cancer diagnosis and treatment. The investment…
ILMN
2 published ideas on Illumina, Inc. across 2 funds — 2 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Illumina: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Diamond Hill views Illumina as the leading producer of next-generation sequencing systems used in DNA research and increasingly in cancer diagnosis and treatment. The investment…
Illumina is the leading producer of next-generation sequencing systems used to sequence DNA for research and increasingly for cancer diagnosis and treatment. Shares strengthened…